e-learning
resources
Breathe
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Con: should asymptomatic patients with moderate-to-severe ?OSA be treated?
Andrew Vakulin, Ching Li Chai-Coetzer, R. Doug McEvoy
Source:
Breathe, 15 (1) 11; 10.1183/20734735.0347-2018
Journal Issue:
March
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Andrew Vakulin, Ching Li Chai-Coetzer, R. Doug McEvoy. Con: should asymptomatic patients with moderate-to-severe ?OSA be treated?. Breathe, 15 (1) 11; 10.1183/20734735.0347-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Pro: should asymptomatic patients with moderate-to-severe OSA be treated?
Source: Breathe, 15 (1) 7; 10.1183/20734735.0340-2018
Year: 2019
Treatment of non-sleepy OSA patients - what are the alternatives ?
Source: Annual Congress 2010 - Practical Workshop: "Treatment of non-sleepy OSA patients"
Year: 2010
Mild OSAS: Is CPAP therapy actually required for these patients?
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
When to treat elderly OSA patients
Source: ERS Conference
Year: 2015
What do patients want? Preferences for two asthma regimens in mild/moderate asthma
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Deprescribing of inhaled corticosteroids in patients with COPD with mild or moderate airflow limitation: what do patients think?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Con: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment
Source: Breathe, 17 (2) 210049; 10.1183/20734735.0049-2021
Year: 2021
Treating OSAS in children
Source: International Congress 2017 – ME1 Treating obstructive sleep apnoea syndrome in children
Year: 2017
Only severe asthma?
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019
Add-on omalizumab therapy for patients with severe persistent allergic (IgE-mediated) asthma: identifying which patients to treat and which patients respond
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006
Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?
Source: ERJ Open Res, 7 (3) 00362-2021; 10.1183/23120541.00362-2021
Year: 2021
Group-delivered speech and language therapy for chronic refractory cough: what do patients want?
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019
Mild persistent asthma: to treat or not to treat regularly?
Source: ERS Live 2007
Year: 2007
Should patients with life-threatening severe asthma be intubated?
Source: Virtual Congress 2021 – PDW End of life care for the elderly asthmatic and COPD patients
Year: 2021
Evolution of patients with severe asthma treated with mepolizumab
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Compliance for NIMV treatment in moderate and severe OSAS patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Anti-inflammatory treatment in 5-10-year-old mildly symptomatic children with asthma: can we objectively measure the effect?
Source: Eur Respir J 2001; 18: Suppl. 33, 495s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept